
AstraZeneca Denies Ongoing Talks for Bristol Myers Squibb Takeover After Share Plunge
AstraZeneca has denied ongoing takeover talks with US rival Bristol Myers Squibb, a move that follows a significant share price drop and subsequent recovery. The situation highlights questions about AstraZeneca's long-term M&A strategy under CEO Sir Pascal Soriot.

















